Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

NCT00117598 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
169
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer